Lein Applied Diagnostics, a company that specialises in innovative and precise optical technology, have closed their latest funding round, receiving investment from two members of Henley Business Angels. This is the second time that Lein have gone through Henley Business Angels for funding, having previously raised a total of £440,000 back in 2017.

Healthcare venture investment in the U.S. and Europe reached a new high in 2018, according to Silicon Valley Bank, the bank of the world’s most innovative companies and their investors. Investment totals in 2018 grew more than 50 percent over 2017, with the activity due in large part to record Series A investments in U.S. biopharma companies.

An innovative treatment for those suffering from the effects of a debilitating medical condition is now a step closer after a significant investment from NorthInvest.

Created by doctors who work on the front line, the technology developed by Renephra helps patients dealing with chronic fluid overload including Lymphoedema – a condition which affects 200 thousand people across the UK.

The treatment aims to improve a patient’s quality of life, allowing them to spend more time with friends, family and loved ones. Treatment which would normally take place in a hospital setting will now be able to be administered at home.

YFM Equity Partners has sold its stake in Mangar Health Limited for an undisclosed sum to Winncare Group Ltd, a leading French medical device company, delivering a 2.7x return to investors. 

Mangar Health designs, manufactures and supplies inflatable bathing and lifting devices, which protect carers from injury and promote independence for people with limited mobility. With a global reach into America, Canada and Australia, Mangar Health also offers a wide international distribution network and additional opportunities in healthcare markets such as emergency services.  The Company is led by CEO Simon Claridge and his team of Finance and Operations Director Craig Butcher, Commercial Director Andrew Macphail and Marketing Director Clare Birt.

A Coventry-firm responsible for creating a web platform that provides online services for general medical consultations and prescriptions has received a £1million funding package. This will allow The GP Service (UK) Limited to create over 60 new roles by 2023 - a five-fold increase in the team’s current size.

eHealth Ventures, the leading Digital Health technological incubator in Israel, has announced the acceptance of its 8^th portfolio company - Engineering for All ("EfA"), managed by Yoel Ezra, an elite IDF technology unit veteran with many years of R&D management experience. eHealth Ventures has invested $900,000 in the company's seed financing round.

eHealth Ventures, the leading Digital Health technological incubator in Israel, has announced the acceptance of its 7th portfolio company - TrainPain, managed by Dr. Elan Schneider DPT, an internationally recognized expert in chronic pain rehabilitation.

OMass Therapeutics, a biopharmaceutical company using structural mass spectrometry to discover novel medicines, has announced completion of a £14 million Series A financing. New investor Syncona Ltd led the round, alongside Oxford Sciences Innovation. The financing supports development of a pipeline of drug development programmes.

Fluidic Analytics, a Cambridge-based life sciences business, has secured a £24m funding package to continue its research and development plans after launching a transformative protein analysis tool. BGF is providing £5m of growth capital in a funding round with Delin Ventures and existing shareholders including Draper Esprit and IQ Capital.

Thermetrix Ltd has secured £500,000 investment for their latest venture to support the development of a diabetic footcare system.  The funding includes £200,000 seed investment from the Development Bank of Wales as well as business angels and corporate support.

The equity investment, which has come from the Wales Technology Seed Fund, will also back the launch of Podium, for both home and professional use, working with nursing homes, podiatrists and other medical professionals.

Established in 2018, Thermetrix, based in Abercynon is working with a team of experts to produce Podium, giving people with diabetes an easy and fast way to check the soles of their feet and seek earlier intervention from their healthcare team to prevent further complications. Using thermal imaging technology, the system can be used to take a daily image of their feet which can then be shared with their podiatrist or GP through a cloud-based dashboard app.

The Riverside Company has signed a definitive agreement to sell its investment in Euromed Botanicals S.A. to Dermapharm Holding SE. Barcelona-based Euromed provides standardized herbal extracts and natural active substances for the pharmaceutical, dietary supplement and cosmetic industries. The transaction is expected to close in the next few months upon receipt of antitrust approval. 

Inovus Medical, a leading designer and manufacturer of medical and surgical simulators, has announced the successful completion of a £500,000 investment from NPIF - Mercia Equity Finance, which is managed by Mercia Fund Managers and part of the Northern Powerhouse Investment Fund.

The investment is part of a £700,000 investment round alongside an angel investor and will help to create four new jobs, accelerating the growth of Inovus Medical’s commercial operations in the domestic and international markets.

The company also plans to utilise the funding to add a suite of new 3D printing technologies to its manufacturing processes and introduce new software additions to its existing product offering.